ResearchMoz

Global Blood Plasma Market Report: 2014 Edition

Koncept Analytics
Published Date » 2014-07-07
No. Of Pages » 84
 Plasma is a composite mixture of more than 700 proteins and other substances which are vital for the smooth functioning of the human body. Plasma is the liquid component of blood, constituting around 50% of the total blood volume. Plasma in itself is approximately 90% water, with the remaining 10% comprising of proteins, minerals, clotting factors, hormones and immunoglobulin which are used for their therapeutic values. 
   
 With the swift changes and advancement in biomedical/healthcare technology, the healthcare/pharmaceutical/therapeutic industry is becoming ever more competitive. Also, increasing incidences of health related issues owing to changing lifestyles is augmenting the blood plasma industry’s growth. In order to address the rising medical needs related to...
Table of Content

1. Overview
1.1 Components of Blood Plasma
1.2 Functions of Blood Plasma
1.3 Collection and Extraction of Plasma
1.3.1 Plasma Collection
1.3.2 Plasma Extraction
1.3.3 Plasma Fractionation Yield
1.3.4 Plasma Usage
 
2. Blood Plasma Market Analysis
2.1 Global Plasma Market
  • Market Value
  • Market Segmentation
  • Breakdown by Region
2.1.1 Plasma Industry Cost Structure
2.2 Global Immunoglobulin (Ig) Market
  • Market Value
  • Market Volume
  • Demand & Supply
  • Volume by Region
  • Per Capita Usage
2.3 Global Hemophilia Market
  • Total Market Value
  • Hemophilia A Market
  • FVIII Demand & Usage
  • Hemophilia B Market
  • FIX Consumption
  • Hemophilia with Inhibitor Market
  • Von Willebrand Disease Market
2.4 Global Albumin Market
2.4.1 Albumin Market of China and the US

3. Market Dynamics
3.1 Key Trends
3.1.1 Kinetics of Plasma-collection Industry
3.1.2 Growth in the US Immunoglobulin Reimbursement
3.1.3 Rise in the US Plasma Collection Centers
3.1.4 Rising Penetration of Episodic Treatment in Emerging Markets
3.1.5 Rising Share of Developing World in Global FVIII Demand
3.1.6 A1PI (Alpha-1 Proteinase Inhibitor) Deficiency- Confined to Prevention only
3.2 Industry Developments
3.2.1 Improved Biological Molecule Formulations
3.2.2 Baxter’s Phase I Clinical Trial of Treatment for Hemophilia A
3.2.3 Global Fractionation Capacity on the Rise
3.3 Growth Drivers
3.3.1 Increasing New Patient Registration for Hemophilia Treatment
3.3.2 Increased Penetration of Plasma Derived Products
3.3.3 Rising Healthcare Expenditure
3.3.4 Launch of NMEs (New Molecular Entities)
3.3.5 Growing Ageing Population
3.3.6 Ameliorating Economic Conditions
3.3.7 China Factor
3.4 Challenges
3.4.1 Increasing Regulation in Plasma-collection Industry
3.4.2 Escalating Price Pressure
3.4.3 Supply Likely to Exceed Demand
3.4.4 Misdiagnosis of the Disease
 
4. Competitive Landscape
4.1 Blood Plasma Market Contention
  • Market Share
  • Sales Comparison
4.2 Plasma Derivatives Market Contention
4.2.1 Immunoglobulin
  • Market Share
  • Sales Comparison
4.2.2 Hemophilia
  • FVIII Market Share
  • Recombinant FVIII Market Share
4.2.3 Albumin

5. Company Profiles
5.1 Baxter International Inc.
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
  • Focus on Investment in R&D
  • Growth through Acquisitions/Collaborations
5.2 Grifols
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
  • Expansion in Other Geographic Regions
  • Growth through Acquisitions in Research Companies
5.3 CSL Limited
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
  • Focus on R&D
  • Expanding Product Portfolio
5.4 Octapharma AG
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies
  • Focus on Innovation and Expansion in Markets
  • Expansion of R&D and Production Facilities
6. Market Outlook
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis

List of Tables


List of Figures

Upcoming Reports:

Greece: live horses and mules market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the live horses and mules market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the live horses and mules market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an...
Poland: sunflower seeds market
By - Williams and Marshal Strategy
ns, the growth and demand drivers of the market and the factors, influencing its development. Last but not least, the report presents a general overview of the economy of Poland in 2008-2012 and a forecast for its development in the medium term. The report on the sunflower seeds market in Poland includes: Analysis and dynamics of the economy of Poland; Forecast for the development of the economy of Poland; Analysis and forecast of market volume and dynamics; Volume, dynamics and analysis of domestic production; Characteristics of market structure (by origin, by types of products,...
Therapeutic Vaccines Market - Global Industry Analysis, Market Share, Size, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Therapeutic vaccines function by triggering a body immune response against a disease. The global therapeutic vaccines market was valued at USD 292 million in 2011. The introduction of therapeutic vaccines has opened up new avenues in the field of chronic disease treatment and prophylactic immunization. Provenge was the first U.S. FDA approved immunotherapy drug to treat prostate cancer in men in 2010, which has encouraged rigorous research and development initiatives by pharmaceutical companies to develop novel vaccines for untapped disease segments. As a result of these...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Hitachi Readies New Suite of Driving Systems
Oct 16, 2014  
Japan’s Hitachi Automotive Systems is all set to unveil a line of innovative autonomous driving technologies as the trend of high-tech and automotive electronics takes the industry by storm. The suite of technologies were unveiled in northern Japan last week and included features such as no-hands self-parking, vehicle stability control in electric automobiles, precrash braking, and...
Canadas Agreement on Waste-Water Treatment Boosts Indias PM Pet Clean Ganga Project
Oct 16, 2014  
In 2008, Canada and India adopted a bilateral science and technology collaboration agreement for Scientific and Technological Cooperation.  The pet Clean Ganga project led by the Indian Prime Minister Narendra Modi has received a confident boost with an agreement earlier on Wednesday. The agreement is all about cleaning up the most heavily used river in the world between Canada...
China Sends Experimental Ebola Drugs to Aid Workers, to Increase Supply if Found Effective
Oct 16, 2014  
An experimental Ebola drug has been sent to Africa for use by Chinese aid worker by a Chinese drug manufacturer. The company is plans to undertake clinical trials of the drug to combat the deadly Ebola outbreak in West Africa that has claimed more than 4000 lives so far. Several thousand doses of the drug JK-05, manufactured by Sihuan Pharmaceutical Holdings Group Ltd, have been...
Broccoli Based Chemical Gives Hope For Treating Autism
Oct 15, 2014  
According to the inferences derived from a small scale clinical trial, the chemical that is extracted from the sprouts of broccoli possess certain anti-cancerous properties. Moreover, this chemical may be able to even treat behavioral symptoms in those suffering from autism spectrum disorders. This research study was carried out by the scientists of Johns Hopkins University School of Medicine...
Toyota China to Recall Crown Sedans Due to Leaking Brake Fluid Issue
Oct 15, 2014  
Joining the global wave of automobile recalls, Toyota has announced its decision to recall 93,700 cars from the Chinese market to fix an issue regarding leaking brake fluid, Chinese quality watchdog has informed.  Tianjin FAW Toyota Motor Co, the Chinese subsidiary of Toyota Motor Corp., will recall the Crown model sedans manufactured by it between 1st December 2009 and 14th June 2012....